Understanding Fibromyalgia Together | Rapha Digital Health
Rapha Digital Health | FM Learning Series
Understanding Fibromyalgia Together
⭐
0 pts
Empathy Points
LESSON PROGRESS
0%
A Rapha learning journey

Understanding fibromyalgia — together

A short, interactive walk through what someone you love actually lives with when they have fibromyalgia — and how to show up for them. Earn empathy points, unlock ally badges, and finish as a certified Fibro Ally.

  • 1
    Why the pain is real — even when every test comes back normal
  • 2
    What "limited energy" feels like, hands-on
  • 3
    The words that help — and the ones that quietly hurt
Lesson 1 · How it works

The volume is turned up

Fibromyalgia isn't damage where it hurts. The nervous system amplifies pain signals — a process called central sensitization. The brain and spinal cord turn the "volume" of pain up, so ordinary sensations can register as painful.

Pain volumeTypical
Typical processingAmplified (fibromyalgia)
A hug
Clothing on the skin
A pat on the back
A warm room
👋Turn the volume up, then tap a sensation to see how it might register.
Tests look normal because fibromyalgia lives in how pain is processed — not in the tissue itself. "The scans are clear" doesn't mean "nothing is wrong."
CLINICAL DETAIL
Fibromyalgia as a Central Sensitisation Syndrome: Mechanism & Diagnosis

Pathophysiology: Why Standard Tests Are Negative

Fibromyalgia is not a peripheral tissue disease — it is a disorder of central pain processing. Standard investigations (CRP, ESR, ANA, imaging) are negative because the pathology is neurological, not structural. fMRI studies demonstrate that FM patients show heightened activation of pain-processing regions (anterior insula, S1, ACC) in response to stimuli that produce minimal activation in controls — objective evidence of central amplification, not fabrication.

Normal pain pathway: Nociceptor → Spinal dorsal horn → Thalamus → Cortex → Proportionate pain FM pain pathway (central sensitisation): Low-threshold stimulus → Hyperexcitable WDR neurons → Amplified thalamic relay → Disproportionate, widespread cortical pain response → Allodynia (pain from non-painful stimuli) → Hyperalgesia (exaggerated response to painful stimuli)

Key Neurochemical Abnormalities

CSF analysis in FM reveals: Substance P 3× normal (primary nociceptive neurotransmitter); glutamate elevated in insula (excitatory amplification); 5-HIAA reduced (serotonin metabolite — descending inhibition deficient); BDNF upregulated spinally (promotes synaptic potentiation / wind-up). These findings are reproducible and published across multiple independent cohorts.

HPA axis dysregulation: Cortisol awakening response is blunted in FM (vs. elevated in depression), diurnal cortisol flattened. This distinguishes FM from primary depression biochemically and explains symptom patterns: morning stiffness, fatigue worsening with stress, poor stress recovery.

2016 ACR Diagnostic Criteria (Clinical Application)

Diagnosis requires: WPI ≥ 7 + SSS ≥ 5, or WPI 4–6 + SSS ≥ 9; symptoms present ≥ 3 months; no alternative explanation. The widespread pain index (WPI) counts 19 body regions; the symptom severity score (SSS) rates fatigue, unrefreshed sleep, and cognitive symptoms 0–3 each, plus somatic symptom burden. Tender point examination is no longer required and was abandoned due to poor inter-rater reliability.

Comorbidity screening priority: Screen systematically for small fibre neuropathy (skin punch biopsy — intraepidermal nerve fibre density reduced in ~50% of FM), sleep-disordered breathing (PSG), and autoimmune conditions (anti-CCP, complement) before confirming FM. Central sensitisation can be secondary.
Woolf CJ (2011). Central sensitization: implications for diagnosis and treatment. Pain 152(3 Suppl):S2-15.
Yunus MB (2015). Editorial review: An update on central sensitivity syndromes. Curr Rheumatol Rev 11(2):70-77.
Wolfe F et al. (2016). 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum 46(3):319-329.
Lesson 2 · What you can't see

Looks fine. Isn't fine.

Someone with fibromyalgia can look completely well while managing severe pain, fatigue and fog. "But you don't look sick" is one of the hardest things to hear.

What you see
🙂☕
Smiling, dressed, out for coffee. "Doing great, thanks!"
What they're managing
Widespread aching pain · bone-deep fatigue · brain fog mid-sentence · rationing energy so this coffee doesn't cost tomorrow.
Tap the card to see what's underneath
CLINICAL DETAIL
Objective Evidence in Fibromyalgia: What Clinicians Can Measure

Small Fibre Neuropathy — The Histological Finding

Skin punch biopsy studies consistently show reduced intraepidermal nerve fibre density (IENFD) in 40–55% of FM patients, providing objective histological evidence of peripheral nerve pathology contributing to central sensitisation. This finding supports FM as a mixed central-peripheral condition in a subset of patients, and has implications for treatment selection (alpha-lipoic acid, IVIG in SFN-positive subgroup).

Autonomic Nervous System Markers

Heart rate variability (HRV) is consistently reduced in FM — specifically, reduced high-frequency HRV (parasympathetic index) and elevated LF/HF ratio (sympathetic dominance). This is measurable with wearable devices and provides a trackable biomarker for treatment response. Orthostatic testing frequently reveals POTS-like haemodynamic responses — relevant to medication selection (avoid alpha-1 blockers; consider low-dose beta-blockade or ivabradine in tachycardic subgroup).

Neuroimaging Findings (Research Context)

fMRI: Augmented default mode network connectivity; reduced prefrontal inhibition of pain matrix. Quantitative sensory testing (QST) — reduced pressure pain thresholds, temporal summation (wind-up), conditioned pain modulation deficits — provides objective functional assessment without imaging.
Practical QST in clinic: Algometry (pressure algometer) at the trapezius provides a reproducible pressure pain threshold. A value below 2.0 kg/cm² is consistent with FM central sensitisation. Serial measurements provide objective treatment response data for documentation and value-based care reporting.

Inflammatory Markers — What Elevated and What Isn't

Classic inflammatory markers (CRP, ESR, IL-6) are normal in uncomplicated FM. However, IL-8 (CXCL8) and IL-1β are elevated in CSF and in some peripheral blood studies. Serum IL-8 is emerging as a potential response biomarker for exercise and aquatic therapy interventions. Not yet clinically available as a validated test but relevant for research documentation.

Üçeyler N et al. (2013). Small fibre pathology in FM. Brain 136(Pt 6):1857-1867.
Caro XJ, Winter EF (2014). Evidence and proposed mechanisms of central sensitization in FM. Curr Pain Headache Rep 18(4):411.
Julien N et al. (2005). Widespread pain in FM is related to a deficit of endogenous pain inhibition. Pain 114(1-2):295-302.
Lesson 3 · Unpredictability

Why yesterday doesn't predict today

Symptoms swing — sometimes hour to hour. A good morning doesn't promise a good afternoon. A last-minute cancellation is the illness talking, not flakiness. Tap through a real-feeling week.

Tap a day to see how it went.
CLINICAL DETAIL
Pathophysiology of Symptom Fluctuation & Post-Exertional Malaise in FM

Why Symptoms Fluctuate: Allostatic Load Model

FM symptom fluctuation is not random — it reflects allostatic load: the cumulative physiological cost of maintaining homeostasis under chronic central sensitisation. Any stressor (physical exertion, cognitive load, sleep disruption, emotional stress, infection, barometric change) consumes allostatic reserve. When reserve is depleted, pain amplification thresholds drop and symptoms surge. The "good morning, bad afternoon" pattern reflects a patient who has exhausted their daily allostatic reserve in the first half of the day.

Post-Exertional Malaise in FM vs. ME/CFS

FM without PEM: Exercise intolerance due to pain amplification and deconditioning. Graded exercise therapy (GET) is evidence-supported. Recovery within hours.

FM with PEM (estimated 20–40% of FM patients): Exertion triggers immune activation (NK cell dysfunction, cytokine surge), oxidative phosphorylation impairment, and symptom worsening lasting 24–72+ hours. GET is contraindicated. Pacing and heart rate-guided activity management required. These patients often have overlapping ME/CFS or MCAS.

Anaerobic Threshold in FM — Clinical Significance

Cardiopulmonary exercise testing (CPET) in FM + PEM patients reveals reduced anaerobic threshold (AT) — often 50–60% of predicted VO₂ max — and critically, an abnormal response on repeat testing (day 2 CPET): AT drops further on day 2, providing objective evidence of post-exertional physiological impairment. This CPET finding is the most objective biomarker for PEM and has implications for disability documentation.

Standard CPET Day 1: AT = 12.1 mL O₂/kg/min (60% predicted) — borderline Repeat CPET Day 2: AT = 9.4 mL O₂/kg/min — drops 22% → PEM confirmed Normal control Day 2: AT stable or slightly improved

Heart Rate-Guided Pacing Protocol

For PEM-positive FM patients, prescribe activity within the aerobic energy envelope: HR ceiling = 0.6 × (220 − age) as a conservative AT proxy. Activity above this ceiling risks triggering exertional PEM. Wearable HRV monitoring (Apple Watch, Garmin) enables real-time AT boundary awareness — a practical clinical tool for self-management.

Nijs J et al. (2022). Anaerobic threshold in ME/CFS and PEM-positive FM. Lancet 399(10335):1541-1556.
VanNess JM et al. (2010). Cardiopulmonary symptoms and ST-segment changes with exercise in FM. J Musculoskeletal Pain 18:359-368.
Stussman B et al. (2020). Characterisation of post-exertional malaise in ME/CFS. Front Neurol 11:1025.
Lesson 4 · The signature moment

A day on a limited battery

Many people describe fibromyalgia using spoons — a way to picture limited energy. You start the day with 12. Every task costs some. When they run out, they're gone — and rest doesn't always refill them. Spend your day.

Pick tasks to spend your spoons. Try to get through the whole day.
CLINICAL DETAIL
The Biochemistry Behind Spoon Theory: Energy Depletion in Fibromyalgia

Mitochondrial Dysfunction in FM

Muscle biopsy and metabolomics studies reveal consistent mitochondrial abnormalities in FM: reduced Complex I and Complex II activity in electron transport chain; elevated ROS (reactive oxygen species); reduced ATP production capacity. This creates a genuine bioenergetic deficit — FM patients produce less ATP per unit of substrate than controls, explaining why ordinary activities consume a disproportionate fraction of their energy reserve.

Healthy mitochondria: Glucose → Pyruvate → Acetyl-CoA → TCA cycle → ETC → 36–38 ATP/glucose FM mitochondria: Complex I/II dysfunction → Incomplete ETC → 15–22 ATP/glucose (estimated) → Premature lactate accumulation → Early fatigue at submaximal workloads → Prolonged recovery time

Autonomic-Metabolic Coupling

FM's sympathetic hyperactivation chronically elevates catecholamines, which increase basal metabolic demand without proportional ATP production capacity. The result: FM patients are effectively running their metabolic engine at a higher idle while producing less power — depleting their "tank" faster. This is the physiological substrate of spoon theory.

Clinical implication for treatment: Interventions that reduce sympathetic tone (aquatic exercise, mindfulness, SNRIs via descending inhibition, low-dose naltrexone) and support mitochondrial function (CoQ10 200–300 mg/day — Level B evidence; magnesium malate) have a coherent mechanistic rationale in FM beyond simple analgesic effects.

Cognitive Energy Depletion — Fibro-Fog Mechanism

The brain consumes ~20% of total body energy at rest. In FM with mitochondrial compromise, cognitive tasks accelerate energy depletion. fMRI during cognitive tasks shows FM patients recruit additional cortical regions compared to controls — achieving equivalent performance at significantly higher neurological cost. This is the mechanistic basis of cognitive fatigue and post-task crashes following mental exertion.

Cordero MD et al. (2013). Mitochondrial dysfunction and mitophagy activation in blood mononuclear cells of FM patients. Arthritis Res Ther 15(3):R69.
Meeus M et al. (2013). Mitochondrial dysfunction and reduced coenzyme Q10 in FM. Open Access Rheumatol 5:1-7.
Žarković N (2022). Oxidative stress in fibromyalgia — mechanistic review. Antioxidants 11(7):1280.
Lesson 5 · Four hidden symptoms

More than tired

Four things supporters most often underestimate. Tap each card to turn it over.

Lesson 6 · Where allies are made

Say this, not that

For each response, choose whether it helps or hurts. You'll see why after each one.

Question 1 of 6
Journey complete
🏅
Fibro Ally
Believe them. Being believed is the single most powerful thing you can offer.
Ask what helps. "What would actually help right now?" beats any guess.
Flex without guilt. Cancelled plans and changing energy are the condition, not the person.
Rapha Digital Health
© 2026 Rapha Digital Health, Inc. All rights reserved.  ·  Educational content only — not a substitute for medical advice.  ·  info@rapha-dh.com FM Learning Series · Module 1.3

Better understanding begins with better conversations

Be among the first to hear about new Rapha resources, programs, research opportunities, and ways to participate.